Moukheibir Catherine's Form 4 filing
MoonLake Immunotherapeutics (MLTX) · filed Jul 7, 2025
- Accession no.
- 0001213900-25-061752
- Filed
- Jul 7, 2025
- Trade date
- Jul 3, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.15M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Moukheibir CatherineCIK 0001772130 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 3, 2025 | Class A ordinary shares, par value $0.0001 per share | MOption exerciseAcquired | +23,500 | $0.00 | $0 | 23,500 | Direct | |
| Jul 3, 2025 | Class A ordinary shares, par value $0.0001 per share | SSaleDisposed | −23,500 | $48.79 | −$1,146,565 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 3, 2025 | Class A ordinary shares, par value $0.0001 per share | MOption exerciseDisposed | −23,500 | $0.00 | $0 | 21,500 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.